Clinical Trial Update: Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of Lactobacillus Casei Shirota on metabolic syndrome and related inflammatory/metabolic parameters.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Lactobacillus Casei Shirota (Lactobacillus casei Shirota)

Snippet

Sponsor: Vanessa Stadlbauer-Koellner, MD | Conditions: Metabolic Syndrome | NA | Status: COMPLETED | Results posted: 2020-04-02